Kazia Therapeutics (KZIA) Return on Capital Employed (2009 - 2011)

Kazia Therapeutics (KZIA) has 3 years of Return on Capital Employed data on file, last reported at 39.13% in Q4 2011.

• In Q4 2011, Return on Capital Employed rose 7748.0% year-over-year to 39.13%; the TTM figure through Dec 2011 stood at 39.13% (up 7748.0% YoY), while the FY2025 annual figure was 27061.88%, down 3060797.0% from the prior year.
• Return on Capital Employed rose to 39.13% in Q4 2011, from 116.6% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 39.13% in Q4 2011 and bottomed at 116.6% in Q4 2010.
• A 3-year average of 76.2% and a median of 72.88% in 2009 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2010 — Return on Capital Employed tumbled 4372 bps — and 2011, when it soared 7748 bps.
• Year by year, Return on Capital Employed stood at 72.88% in 2009, then tumbled by 60 bps to 116.6% in 2010, then surged by 66 bps to 39.13% in 2011.
• The last three Return on Capital Employed figures came in at 39.13% (Q4 2011), 116.6% (Q4 2010), and 72.88% (Q4 2009), per Business Quant data.

Peer Comparison